Department of Ophthalmology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Department of Ophthalmology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, 610031, China.
J Nanobiotechnology. 2024 Jun 20;22(1):354. doi: 10.1186/s12951-024-02614-1.
Fundus neovascularization diseases are a series of blinding eye diseases that seriously impair vision worldwide. Currently, the means of treating these diseases in clinical practice are continuously evolving and have rapidly revolutionized treatment opinions. However, key issues such as inadequate treatment effectiveness, high rates of recurrence, and poor patient compliance still need to be urgently addressed. Multifunctional nanomedicine can specifically respond to both endogenous and exogenous microenvironments, effectively deliver drugs to specific targets and participate in activities such as biological imaging and the detection of small molecules. Nano-in-micro (NIM) delivery systems such as metal, metal oxide and up-conversion nanoparticles (NPs), quantum dots, and carbon materials, have shown certain advantages in overcoming the presence of physiological barriers within the eyeball and are widely used in the treatment of ophthalmic diseases. Few studies, however, have evaluated the efficacy of NIM delivery systems in treating fundus neovascular diseases (FNDs). The present study describes the main clinical treatment strategies and the adverse events associated with the treatment of FNDs with NIM delivery systems and summarizes the anatomical obstacles that must be overcome. In this review, we wish to highlight the principle of intraocular microenvironment normalization, aiming to provide a more rational approach for designing new NIM delivery systems to treat specific FNDs.
眼底新生血管疾病是一系列致盲性眼病,严重影响全球视力。目前,临床实践中治疗这些疾病的手段不断发展,治疗观点迅速发生变革。然而,治疗效果不佳、复发率高和患者依从性差等关键问题仍亟待解决。多功能纳米医学可以特异性地对内源性和外源性微环境做出响应,将药物有效地递送到特定的靶标,并参与生物成像和小分子检测等活动。金属、金属氧化物和上转换纳米粒子(NPs)、量子点和碳材料等纳米-微(NIM)递药系统在克服眼球内生理屏障方面显示出一定的优势,广泛应用于眼部疾病的治疗。然而,很少有研究评估 NIM 递药系统在治疗眼底新生血管疾病(FNDs)方面的疗效。本研究描述了 NIM 递药系统治疗 FNDs 的主要临床治疗策略和相关不良反应,并总结了必须克服的解剖学障碍。在这篇综述中,我们希望强调眼内微环境正常化的原则,旨在为设计新的 NIM 递药系统以治疗特定的 FNDs 提供更合理的方法。